COVID-19 Updates
News from the FDA/CDC
U.S. allows pharmacists to prescribe Paxlovid directly
“Since Paxlovid must be taken within 5 days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access...
Latest News
WHO tracking new Omicron subvariant in India
BA.2.75 has eight mutations beyond those seen in BA.5, which “could make immune escape worse than what we’re seeing now.”
Latest News
Experimental cancer drug promising for hospitalized COVID patients
The manufacturer is seeking emergency use authorization from the Food and Drug Administration.
Conference Coverage
Skin reactions after COVID-19 vaccination have six patterns
“This is the first study that analyzes a significant number of cases assessed by dermatologists and illustrated with clinical images.”
Conference Coverage
What are the benefits of a fourth vaccination against COVID?
“For the over-60s, protection is almost quadrupled through the fourth vaccination. However, this is still plagued with a lot of uncertainty.”
From the Journals
Study confirms increased CVT with AstraZeneca COVID vaccine
“Reassuringly, no consistent association was observed between the Pfizer and Moderna mRNA vaccines and these rare complications.”
Latest News
Pfizer plans a vaccine to target all coronaviruses
Trials are expected to begin this fall.
Latest News
Acute hepatitis cases in children show declining trend; adenovirus, COVID-19 remain key leads
Adenovirus remains the most commonly detected virus in acute hepatitis in children, found in 53% of cases overall.
Conference Coverage
COVID-19 tied to increased risk for Alzheimer’s disease and Parkinson’s disease
But the risk was no greater than that following any other respiratory infections such as influenza or community-acquired bacterial pneumonia.
News
FDA panel backs adding Omicron component to COVID boosters
Latest News
COVID subvariants could cause ‘substantial’ summer cases